Health ❯ Healthcare ❯ Medical Research ❯ Cancer Treatment

Immunotherapy

Early Trial of VIR-5500 Shrinks Tumors in 45% of Advanced Prostate Cancer Cases

Investigators plan larger studies following promising early signals.

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

IIT Bombay Study Identifies Gentler Enzyme to Retrieve Lab-Grown T Cells for Cancer Therapy

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

mRNA Covid Vaccination Linked to Longer Survival When Given Near Cancer Immunotherapy, Nature Study Finds

Cambridge Researchers Demonstrate Tumor-Triggered Two-Part STING Prodrug

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

UCLA Details Off-the-Shelf CAR-NKT Therapy With Preclinical Success in Metastatic Kidney Cancer

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

Intratumoral Fc-Optimized CD40 Antibody Achieves Systemic Remissions in Phase 1 Study

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

NHS Opens Pre-Treatment Immunotherapy Trial for Glioblastoma

Nature Study Shows Gut Bacterium YB328 Boosts Cancer Immunotherapy

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer